Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-01 7:39 pm Purchase |
2022-12-30 | 13G | Innoviva, Inc. INVA |
Westfield Capital Management Company, L.P. | 4,106,136 5.880% |
422,651 (+11.47%) |
Filing History |
| 2023-01-26 08:52 am Purchase |
2022-12-31 | 13G | Innoviva, Inc. INVA |
BlackRock Inc. BLK |
10,611,839 10.600% |
4,940,739 (+87.12%) |
Filing History |
| 2023-01-20 5:17 pm Sale |
2022-12-31 | 13G | Innoviva, Inc. INVA |
BlackRock Inc. BLK |
5,671,100 10.600% |
-3,337,658 (-37.05%) |
Filing History |
| 2023-01-10 5:12 pm Purchase |
2023-01-10 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
64,178,259 85.300% |
19,736,843 (+44.41%) |
Filing History |
| 2022-07-11 5:27 pm Sale |
2022-07-07 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
100 100.000% |
-57,345,694 (-100.00%) |
Filing History |
| 2022-07-11 1:13 pm Purchase |
2022-06-30 | 13G | Innoviva, Inc. INVA |
The Vanguard Group | 6,970,950 10.000% |
170,755 (+2.51%) |
Filing History |
| 2022-05-23 8:55 pm Unchanged |
2022-05-23 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 74.930% |
0 (Unchanged) |
Filing History |
| 2022-04-01 4:50 pm Purchase |
2022-03-31 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
44,441,416 80.100% |
8,077,812 (+22.21%) |
Filing History |
| 2022-03-15 09:00 am Unchanged |
2022-03-15 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 74.930% |
0 (Unchanged) |
Filing History |
| 2022-02-18 8:47 pm Unchanged |
2022-02-17 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 75.150% |
0 (Unchanged) |
Filing History |
| 2022-02-11 3:15 pm Purchase |
2022-02-09 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
36,363,604 76.700% |
5,422,188 (+17.52%) |
Filing History |
| 2022-02-11 2:10 pm Sale |
2021-12-31 | 13G | Innoviva, Inc. INVA |
Renaissance Technologies LLC | 5,295,133 7.620% |
-2,196,209 (-29.32%) |
Filing History |
| 2022-02-10 08:17 am Purchase |
2021-12-31 | 13G | Innoviva, Inc. INVA |
The Vanguard Group | 6,800,195 9.790% |
204,712 (+3.10%) |
Filing History |
| 2022-02-01 6:34 pm Unchanged |
2022-02-01 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 75.150% |
0 (Unchanged) |
Filing History |
| 2022-02-01 1:48 pm Purchase |
2021-12-31 | 13G | Innoviva, Inc. INVA |
Westfield Capital Management Company, L.P. | 3,683,485 5.300% |
3,683,485 (New Position) |
Filing History |
| 2022-01-28 1:54 pm Sale |
2021-12-31 | 13G | Innoviva, Inc. INVA |
BlackRock Inc. BLK |
9,008,758 13.000% |
-2,151,788 (-19.28%) |
Filing History |
| 2021-11-01 09:27 am Purchase |
2021-10-28 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
30,941,416 73.800% |
30,941,416 (New Position) |
Filing History |
| 2021-06-11 5:37 pm Purchase |
2021-06-11 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 75.500% |
29,345,794 (+104.81%) |
Filing History |
| 2021-06-07 4:43 pm Sale |
2021-05-31 | 13G | Innoviva, Inc. INVA |
Renaissance Technologies LLC | 7,491,342 10.790% |
-390,460 (-4.95%) |
Filing History |
| 2021-05-25 5:05 pm Unchanged |
2021-05-25 | 13D | Innoviva, Inc. INVA |
Sarissa Capital Management LP | 6,414,000 9.240% |
0 (Unchanged) |
Filing History |